Avalon Ventures is an early stage venture capital fund focused on information technology and life sciences.
Business Model:
Revenue: $6.7M
Employees: 2-10
Address: 1134 Kline Street
City: La Jolla
State: CA
Zip: 92037
Country: US
Avalon’s long-standing and successful focus has been on seed and early stage companies, including many it formed in the life science and information technology sectors. We believe this is the most challenging and rewarding period of company creation – we are former entrepreneurs driven by passionate people pursuing disruptive ideas in ever changing market environments.
Contact Phone:
+18583482180
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/1999 | TomoTherapy | Series A | 3M |
2/2015 | Overlap.cc | Pre Seed Round | - |
9/2010 | Backupify | Series A | 4.5M |
1/2014 | Chartio | Venture Round | 2.2M |
5/2018 | BotChain | Venture Round | 5M |
4/2017 | NanoNets | Seed Round | 1.4M |
9/2021 | Joy | Series A | 0 |
3/2007 | Amira Pharmaceuticals | Series B | 25M |
11/2008 | Zacharon Pharmaceuticals | Series A | 3.5M |
4/2013 | Nanigans | Series A | 5.8M |
1/2012 | MOGL | Series B | 12M |
7/2016 | AristaMD | Series A | 11M |
4/2018 | Synthorx | Series C | 63M |
1/2013 | LoopIt | Seed Round | - |
10/2003 | BioVex | Series C | 28.4M |
6/2008 | Kaltura | Series B | 21M |
4/2003 | Ansata Therapeutics | Series B | 2.5M |
6/2015 | Ankasa Regenerative Therapeutics | Series A | 8.5M |
4/2020 | Figg | Funding Round | - |
2/2011 | Kaltura | Series C | 20M |
10/2014 | StackIQ | Series B | 6M |
11/2007 | BioVex | Series E | 35M |
7/2014 | ScoreStream | Convertible Note | 800k |
7/2006 | AnaptysBio | Series A | 2M |
2/1992 | Metra Biosystems | Venture Round | - |
5/2009 | E-Band Communications | Series C | - |
9/2011 | RethinkDB | Series A | 0 |
9/2014 | Sidecar Technologies | Series C | 15M |
12/2015 | AlphaSheets | Seed Round | 5.5M |
10/2012 | Proximal Data | Series A | 3M |
2/2014 | Empyr | Series B | 10.5M |
5/2013 | Happy Cloud | Series A | 4.3M |
7/2012 | Backupify | Series C | 9M |
12/2010 | Cloudant | Series A | 1M |
6/2006 | Kalon Semiconductor | Series A | 10.9M |
6/2021 | Primer | Series C | 0 |
2/2012 | Memrise | Seed Round | 0 |
9/2011 | Backupify | Series B | 5M |
11/2014 | Redbooth | Series B | 11M |
3/2017 | Smyte | Series A | 4M |
6/2012 | Cardeas Pharma | Series A | 8.5M |
2/2013 | Simulmedia | Series C | 5M |
11/2012 | Pingup | Series A | 4M |
1/2015 | Primer | Seed Round | - |
1/2014 | Quippi | Venture Round | 2M |
6/2015 | Calporta Therapeutics | Series A | 10M |
12/2012 | Cheezburger | Venture Round | 5M |
5/2007 | Kaltura | Series A | 2.1M |
12/2000 | Ambit Biosciences | Series B | 18.8M |
1/2011 | Cheezburger | Venture Round | 30M |
2/2000 | ChoiceSeat technology | Venture Round | 22.4M |
11/2006 | Amira Pharmaceuticals | Series A | 4M |
3/2018 | Averon | Series A | 11.7M |
7/2007 | Awarepoint | Series B | 2M |
3/2020 | AristaMD | Series B | 0 |
10/2017 | Averon | Series A | 8.3M |
1/2010 | Pictela | Venture Round | 1.5M |
9/2014 | Kinvey | Series B | 10.9M |
10/2011 | Chartio | Series A | 3.1M |
7/2011 | Shelby.tv | Seed Round | 1.5M |
10/2018 | Seva Inc. | Seed Round | 2.4M |
6/2012 | Awarepoint | Venture Round | 14M |
12/2008 | Awarepoint | Series D | 13.3M |
11/2011 | Standing Cloud | Venture Round | 3M |
5/2005 | Ambit Biosciences | Series C | 31M |
6/2010 | Otonomy | Series A | 10M |
2/2016 | Orion Labs | Series A | 9M |
5/2014 | BookBub | Series A | 3.8M |
4/2010 | Cloudkick | Series A | 2M |
8/2011 | Nanigans | Series A | 3M |
10/2012 | Selectable Media | Series A | 2M |
11/2010 | Standing Cloud | Series B | 3M |
1/2015 | StackRox | Seed Round | - |
11/2008 | Selectable Media | Venture Round | 2.6M |
3/2014 | Indix | Series A | 8.5M |
3/2006 | Awarepoint | Series A | 4M |
9/2014 | Avelas Biosciences | Series B | 7.4M |
10/2007 | Awarepoint | Series C | 3M |
1/2014 | Avelas Biosciences | Series B | 6.8M |
3/2011 | Tapad | Angel Round | 0 |
1/2009 | Pictela | Series A | 1.3M |
7/2012 | Shelby.tv | Series A | 2.2M |
11/2017 | ScoreStream | Series A | 0 |
10/2004 | Vocera Communications | Venture Round | 6M |
11/2006 | Vocera Communications | Series F | 7M |
2/2005 | Cambrios Technologies | Series B | 12M |
4/2007 | Cambrios Technologies | Series C | 18.5M |
11/2009 | Cambrios Technologies | Series D | 14.5M |
4/2013 | Indix | Series A | 6M |
12/2011 | Cloudant | Venture Round | 2.1M |
12/2013 | Simulmedia | Series D | 25M |
7/2015 | AeroFS | Series B | 10M |
1/2015 | Primer | Venture Round | - |
8/2015 | MOGL | Venture Round | 7.9M |
10/2014 | Empyr | Venture Round | 11M |
8/2015 | Skycatch | Series B | 0 |
9/2013 | Otonomy | Series C | 45.9M |
3/2021 | Janux Therapeutics | Series A | 0 |
9/2014 | Thyritope Biosciences | Series A | 10M |
10/2014 | MOGL | Venture Round | 11M |
4/2015 | Cardeas Pharma | Series B | 37.5M |
5/2015 | Tapad | Series B | 0 |
9/2008 | Afraxis | Series A | 1.5M |
4/2013 | Proximal Data | Series B | 2M |
6/2010 | Chartio | Seed Round | 0 |
12/2017 | Pando | Seed Round | 3.1M |
8/2021 | Jnana Therapeutics | Series B | 50M |
6/2017 | Talla | Series A | 8.3M |
8/2016 | Avelas Biosciences | Series C | 0 |
6/2015 | Pronoun | Series B | 3.5M |
10/2011 | TwinStrata | Series B | 8M |
7/2012 | Byliner | Series A | - |
6/2020 | Pando | Series A | 0 |
5/2014 | Skycatch | Venture Round | 13.2M |
7/2013 | Conjur | Seed Round | - |
10/2013 | Redbooth | Series A | 5M |
1/2011 | Aratana Therapeutics | Series A | 0 |
8/2005 | Intercasting | Series A | 5.5M |
12/2015 | Enlibrium | Series A | 15M |
3/2013 | Tapad | Series B | 6.5M |
5/2007 | Intercasting | Series B | 12M |
10/2009 | JustSpotted | Seed Round | 750k |
4/2014 | Synthorx | Series A | 3.1M |
11/2012 | Kaltura | Series D | 25M |
6/2018 | Memrise | Series B | 15.5M |
11/2013 | Sitari Pharmaceuticals | Series A | 10M |
9/2014 | Silarus Therapeutics | Series A | 10M |
2/2011 | RQx Pharmaceuticals | Series A | 7M |
4/2012 | Simulmedia | Series C | 6M |
6/2015 | Cadherx Therapeutics | Series A | 10M |
12/2012 | Avelas Biosciences | Series A | 7.7M |
3/2008 | Chumby | Series B | 12.5M |
11/2007 | AnaptysBio | Series B | 0 |
2/2011 | MOGL | Series A | 2.4M |
7/2012 | Kinvey | Series A | 5M |
5/2015 | BookBub | Series B | 7M |
6/2015 | Indix | Series B | 15M |
7/2008 | Zynga | Series B | 25M |
11/2022 | Jnana Therapeutics | Series C | 0 |
8/2015 | Empyr | Venture Round | 7.9M |
2/2007 | Inogen | Series D | 22M |
6/2019 | Simulmedia | Series E | 29M |
3/2020 | Orion Labs | Series B | 0 |
9/2018 | Joy | Series A | 0 |
6/2014 | Tapad | Series B | 0 |
2/2014 | Sidecar Technologies | Series B | 10M |
1/2008 | Zynga | Series A | 0 |
2/2008 | Zynga | Series A | 5M |
3/2009 | Simulmedia | Series A | 4M |
5/2011 | Simulmedia | Series C | 9.3M |
4/2010 | Simulmedia | Series B | 8M |
4/2021 | Janux Therapeutics | Series B | 0 |
7/2016 | Synthorx | Series B | 10M |
10/2022 | Enlaza Therapeutics | Seed Round | 61M |
12/2011 | Aratana Therapeutics | Series B | 15M |
2/2014 | MOGL | Series B | 10.5M |
4/2007 | Syndax Pharmaceuticals | Series A | 40M |
3/2010 | Syndax Pharmaceuticals | Series A | 9M |
7/2019 | Node | Venture Round | 0 |
12/2017 | Jnana Therapeutics | Series A | 50M |
4/2014 | Otonomy | Series D | 49M |
8/2005 | Amira Pharmaceuticals | Series A | 3M |
2/2011 | Empyr | Series A | 2.4M |
1/2012 | Empyr | Series B | 12M |
9/2011 | Techstars | Venture Round | 24M |
4/2015 | ScoreStream | Seed Round | 3M |
6/2016 | Node | Seed Round | 7.5M |
12/2014 | Conjur | Venture Round | 2.6M |
5/2013 | Cloudant | Series B | 12M |
9/2009 | Cloudkick | Seed Round | 750k |
4/2010 | RethinkDB | Seed Round | 1.2M |
3/2010 | Ad Summos | Venture Round | 3M |
6/2007 | Ortiva Wireless | Series B | 15M |
9/2016 | Fortis Therapeutics | Series A | 18M |
3/2021 | Fortis Therapeutics | Series A | 0 |
2/2017 | Piper Networks | Venture Round | 5.8M |
3/2015 | Nanigans | Series B | 24M |
12/2008 | Cloudant | Series A | 1M |
12/2006 | Chumby | Series A | 5M |
9/2021 | Joy | Series A | 0 |
8/2021 | Jnana Therapeutics | Series B | 0 |
6/2021 | Primer | Series C | 0 |
4/2021 | Janux Therapeutics | Series B | 0 |
3/2021 | Fortis Therapeutics | Series A | 0 |
3/2021 | Janux Therapeutics | Series A | 0 |
6/2020 | Pando | Series A | 0 |
4/2020 | Figg | Funding Round | - |
3/2020 | AristaMD | Series B | 0 |
3/2020 | Orion Labs | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|